Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience

Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience

Purpose: To characterize our experience and the disease control and toxicity of proton therapy (PT) for patients with head and neck cancer (HNC). Patients and Methods: Clinical outcomes for patients with HNC treated with PT at our institution were prospectively collected in 2 institutional review bo...

Full description

Bibliographic Details
Main Authors: G. Brandon Gunn, MD, Adam S. Garden, MD, Rong Ye, MSc, Noveen Ausat, BA, Kristina R. Dahlstrom, PhD, William H. Morrison, MD, C. David Fuller, MD, PhD, Jack Phan, MD, PhD, Jay P. Reddy, MD, PhD, Shalin J. Shah, MD, Lauren L. Mayo, MD, Stephen G. Chun, MD, Gregory M. Chronowski, MD, Amy C. Moreno, MD, Jeffery N. Myers, MD, PhD, Ehab Y. Hanna, MD, Bita Esmaeli, MD, Maura L. Gillison, MD, PhD, Renata Ferrarotto, MD, Katherine A. Hutcheson, PhD, Mark S. Chambers, DMD, MS, Lawrence E. Ginsberg, MD, Adel K. El-Naggar, MD, PhD, David I. Rosenthal, MD, Xiaorong Ronald Zhu, PhD, Steven J. Frank, MD
Format: Article
Language:English
Published: Particle Therapy Co-operative Group 2021-06-01
Series:International Journal of Particle Therapy
Subjects:
proton therapy
head and neck cancer
toxicity
survival
Online Access:https://theijpt.org/doi/pdf/10.14338/IJPT-20-00065.1

Internet

https://theijpt.org/doi/pdf/10.14338/IJPT-20-00065.1

Similar Items